CSS
AGRX

Cubist Systematic Strategies’s Agile Therapeutics AGRX Stock Holding History

Cubist Systematic Strategies’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-34
Closed -$141K – 3176
2021
Q1 		$141K Buy
+34
New +$184K ﹤0.01% 2576
2020
Q4 		– Sell
-26
Closed -$160K – 2768
2020
Q3 		$160K Sell
26
-6
-19% -$34.4K ﹤0.01% 2192
2020
Q2 		$178K Buy
32
+6
+23% +$31.2K ﹤0.01% 2075
2020
Q1 		$96K Buy
+26
New +$149K ﹤0.01% 1917
2017
Q1 		– Sell
-1
Closed -$15K – 1923
2016
Q4 		$15K Buy
+1
New +$14K ﹤0.01% 1643

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return